Endo presses pause on litigation after FDA assurance to sort out compounding competition by year-end

Endo presses pause on litigation after FDA assurance to sort out compounding competition by year-end

Submitted by admin on September 24, 2018 - 8:22pm
Source: 
Fierce Pharma
News Tags: 
FDA
Endo Pharmaceuticals
compounded drugs
Headline: 
Endo presses pause on litigation after FDA assurance to sort out compounding competition by year-end
snippet: 
Endo Pharmaceuticals’ on-again, off-again lawsuit, aimed at keeping the FDA from giving bulk compounders the ability to compete with one of it key drugs, is off again.

Do Not Allow Advertisers to Use My Personal information